CLINICAL TRIALS PROFILE FOR DEXEDRINE

All Clinical Trials for Dexedrine

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00296686 ↗	Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression	Terminated	New York State Psychiatric Institute	Phase 4	2001-09-01	This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression.
NCT00363298 ↗	Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD	Completed	Obsessive Compulsive Foundation	N/A	2006-08-01	The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks.
NCT00363298 ↗	Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD	Completed	Stanford University	N/A	2006-08-01	The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks.
NCT00439049 ↗	Substance Abuse Pre-Treatment Screening Study	Recruiting	National Institute on Drug Abuse (NIDA)		2005-10-01	The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.
NCT00439049 ↗	Substance Abuse Pre-Treatment Screening Study	Recruiting	The University of Texas Health Science Center, Houston		2005-10-01	The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.
NCT00794625 ↗	Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)	Unknown status	Northwell Health	Phase 4	2008-11-01	This study will determine the advantages and disadvantages of adding one of two different types of drugs to stimulant treatment for reducing aggressive behavior in children with attention deficit with hyperactivity disorder (ADHD).

Clinical Trial Conditions for Dexedrine

Condition Name

Condition Name for Dexedrine
Intervention	Trials
Attention Deficit Hyperactivity Disorder	4
Attention Deficit Hyperactivity Disorder (ADHD)	2
Cocaine Abuse	1
Cocaine Dependence	1

Condition MeSH

Condition MeSH for Dexedrine
Intervention	Trials
Hyperkinesis	7
Disease	7
Attention Deficit Disorder with Hyperactivity	7
Cocaine-Related Disorders	2

Clinical Trial Locations for Dexedrine

Trials by Country

Trials by Country for Dexedrine
Location	Trials
United States	12
Canada	6

Trials by US State

Trials by US State for Dexedrine
Location	Trials
Texas	4
Massachusetts	2
California	2
New York	2
Connecticut	1

Clinical Trial Progress for Dexedrine

Clinical Trial Phase

Clinical Trial Phase for Dexedrine
Clinical Trial Phase	Trials
Phase 4	5
Phase 2	4
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for Dexedrine
Clinical Trial Phase	Trials
Unknown status	5
Completed	5
Recruiting	4

Clinical Trial Sponsors for Dexedrine

Sponsor Name

Sponsor Name for Dexedrine
Sponsor	Trials
The University of Texas Health Science Center, Houston	4
Canadian Institutes of Health Research (CIHR)	3
McGill University Health Center	3

Sponsor Type

Sponsor Type for Dexedrine
Sponsor	Trials
Other	27
NIH	2
Industry	1